Lista de obras - Rob Boer - Dominio Público Uruguay

A Comparison of Disease Specific Survival of Patients Who Died of and Who Had Newly Diagnosed Prostate Cancer

artículo científico publicado en 1997

A longer breast carcinoma screening interval for women age older than 65 years?

artículo científico publicado en 1999

A model-based prediction of the impact on reduction in mortality by a breast cancer screening programme in the city of Florence, Italy

artículo científico publicado en 1995

A novel hypothesis on the sensitivity of the fecal occult blood test: Results of a joint analysis of 3 randomized controlled trials

artículo científico publicado en 2009

Breast cancer screening in Navarra: interpretation of a high detection rate at the first screening round and a low rate at the second round.

artículo científico publicado en 1997

Breast cancer screening: Evidence for false reassurance?

artículo científico publicado en 2008

Cardiovascular and Renal Outcomes Trials-Is There a Difference?

artículo científico

Chapter 7: Description of MISCAN-lung, the Erasmus MC Lung Cancer microsimulation model for evaluating cancer control interventions

artículo científico publicado en 2012

Chapter 9: The MISCAN-Fadia Continuous Tumor Growth Model for Breast Cancer

artículo científico publicado en 2006

Colorectal cancer risk in adenoma patients: a nation-wide study.

artículo científico publicado en 2004

Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study.

artículo científico publicado en 1998

Cost-Effectiveness of Cervical Cancer Screening: Comparison of Screening Policies

artículo científico publicado en 2002

Cost-effectiveness of Mammography Screening

artículo científico publicado en 1996

Cost-effectiveness of cinacalcet in secondary hyperparathyroidism in the United States ⬇️

artículo científico publicado el 21 de febrero de 2012

Cost-effectiveness of mammographic screening in Australia

artículo científico publicado en 2010

Developing and interpreting models to improve diagnostics in developing countries.

artículo científico publicado en 2006

Diversity of model approaches for breast cancer screening: a review of model assumptions by the Cancer Intervention and Surveillance Network (CISNET) Breast Cancer Groups.

artículo científico publicado en 2004

Endoscopic colorectal cancer screening: a cost-saving analysis

artículo científico publicado en 2000

Exploring the uncertainties of early detection results: model-based interpretation of mayo lung project.

artículo científico publicado en 2011

Extra incidence caused by mammographic screening

artículo científico publicado en 1994

How cost-effective is breast cancer screening in different EC countries?

artículo científico publicado en 1993

How much can current interventions reduce colorectal cancer mortality in the U.S.?

artículo científico publicado en 2006

Human papillomavirus triage of women with persistent borderline or mildly dyskaryotic smears: Comparison of costs and side effects of three alternative strategies

artículo científico publicado en 2007

Impact of Reduced Tobacco Smoking on Lung Cancer Mortality in the United States During 1975–2000 ⬇️

artículo científico publicado el 14 de marzo de 2012

Impact of systematic false-negative test results on the performance of faecal occult blood screening

artículo científico publicado en 2001

In search of the best upper age limit for breast cancer screening

artículo científico publicado en 1995

Incidence of cervical cancer after several negative smear results by age 50: prospective observational study

artículo científico publicado en 2009

Increased risk of adenomas in individuals with a family history of colorectal cancer: results of a meta-analysis ⬇️

artículo científico publicado el 28 de octubre de 2010

Individualizing colonoscopy screening by sex and race

artículo científico publicado en 2009

Interval cancers in the Dutch breast cancer screening programme.

artículo científico publicado en 1999

Investigation of Design and Bias Issues in Case-Control Studies of Cancer Screening Using Microsimulation

artículo científico publicado en 2000

Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysis

artículo científico publicado en 2013

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

artículo científico publicado en 2003

Mammography benefit in the Canadian National Breast Screening Study-2: a model evaluation

artículo científico publicado en 2004

Mammography screening and risk of breast cancer death: a population-based case-control study.

artículo científico publicado en 2011

Modelling issues in cancer screening.

artículo científico publicado en 1995

Nation-wide breast cancer screening in The Netherlands: results of initial and subsequent screening 1990-1995. National Evaluation Team for Breast Cancer Screening.

artículo científico publicado en 1998

Nation-wide breast cancer screening in the Netherlands: Support for breast-cancer mortality reduction

artículo científico publicado en 1995

National Polyp Study data: evidence for regression of adenomas

artículo científico publicado en 2004

Nationwide breast cancer screening programme fully implemented in The Netherlands

artículo científico publicado en 2001

Neighborhood design and walking trips in ten U.S. metropolitan areas.

artículo científico publicado en 2007

No increased risk for cervical cancer after a broader definition of a negative Pap smear

artículo científico publicado en 2008

Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends

artículo científico publicado en 2002

Pathologic Features of Prostate Cancer Found at Population-Based Screening With a Four-Year Interval

artículo científico publicado en 2001

Prostate cancer mortality reduction by screening: Power and time frame with complete enrollment in the European randomised screening for prostate cancer (ERSPC) trial

artículo científico publicado en 2001

Prostate-specific antigen screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer-Rotterdam.

artículo científico publicado en 2010

Quantitative Interpretation of Age-Specific Mortality Reductions From the Swedish Breast Cancer-Screening Trials

artículo científico publicado en 1995

Quebec randomized controlled trial on prostate cancer screening shows no evidence for mortality reduction

artículo científico publicado en 1999

Radiation risk of mammography related to benefit in screening programmes: a favourable balance?

artículo científico publicado en 1998

Re: Improving the Cost-Effectiveness of Colorectal Cancer Screening

artículo científico publicado en 2000

Reducing the global burden of acute lower respiratory infections in children: the contribution of new diagnostics

artículo científico publicado en 2006

Screening for breast cancer. Incidence of interval cancer and detection rate of first screenings are inconsistent.

artículo científico publicado en 1995

Seventy-five years is an appropriate upper age limit for population-based mammography screening

artículo científico publicado en 2005

Simulation of colorectal cancer screening: What we do and do not know and does it matter ⬇️

artículo científico publicado el 1 de agosto de 2010

Stage distribution at first and repeat examinations in breast cancer screening

artículo científico publicado en 1999

The MISCAN-COLON Simulation Model for the Evaluation of Colorectal Cancer Screening

artículo científico publicado en 1999

Transmission patterns of smallpox: systematic review of natural outbreaks in Europe and North America since World War II.

artículo científico publicado en 2006

Validity of Race, Ethnicity, and National Origin in Population-based Cancer Registries and Rapid Case Ascertainment Enhanced With a Spanish Surname List ⬇️

artículo científico publicado el 1 de enero de 2016

Withdrawing low risk women from cervical screening programmes. Conclusions cannot yet be drawn

artículo científico publicado en 1999

Lista de obras de Rob Boer

A Comparison of Disease Specific Survival of Patients Who Died of and Who Had Newly Diagnosed Prostate Cancer

A longer breast carcinoma screening interval for women age older than 65 years?

A model-based prediction of the impact on reduction in mortality by a breast cancer screening programme in the city of Florence, Italy

A novel hypothesis on the sensitivity of the fecal occult blood test: Results of a joint analysis of 3 randomized controlled trials

Breast cancer screening in Navarra: interpretation of a high detection rate at the first screening round and a low rate at the second round.

Breast cancer screening: Evidence for false reassurance?

Cardiovascular and Renal Outcomes Trials-Is There a Difference?

Chapter 7: Description of MISCAN-lung, the Erasmus MC Lung Cancer microsimulation model for evaluating cancer control interventions

Chapter 9: The MISCAN-Fadia Continuous Tumor Growth Model for Breast Cancer

Colorectal cancer risk in adenoma patients: a nation-wide study.

Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study.

Cost-Effectiveness of Cervical Cancer Screening: Comparison of Screening Policies

Cost-effectiveness of Mammography Screening

Cost-effectiveness of cinacalcet in secondary hyperparathyroidism in the United States ⬇️

Cost-effectiveness of mammographic screening in Australia

Developing and interpreting models to improve diagnostics in developing countries.

Diversity of model approaches for breast cancer screening: a review of model assumptions by the Cancer Intervention and Surveillance Network (CISNET) Breast Cancer Groups.

Endoscopic colorectal cancer screening: a cost-saving analysis

Exploring the uncertainties of early detection results: model-based interpretation of mayo lung project.

Extra incidence caused by mammographic screening

How cost-effective is breast cancer screening in different EC countries?

How much can current interventions reduce colorectal cancer mortality in the U.S.?

Human papillomavirus triage of women with persistent borderline or mildly dyskaryotic smears: Comparison of costs and side effects of three alternative strategies

Impact of Reduced Tobacco Smoking on Lung Cancer Mortality in the United States During 1975–2000 ⬇️

Impact of systematic false-negative test results on the performance of faecal occult blood screening

In search of the best upper age limit for breast cancer screening

Incidence of cervical cancer after several negative smear results by age 50: prospective observational study

Increased risk of adenomas in individuals with a family history of colorectal cancer: results of a meta-analysis ⬇️

Individualizing colonoscopy screening by sex and race

Interval cancers in the Dutch breast cancer screening programme.

Investigation of Design and Bias Issues in Case-Control Studies of Cancer Screening Using Microsimulation

Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysis

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

Mammography benefit in the Canadian National Breast Screening Study-2: a model evaluation

Mammography screening and risk of breast cancer death: a population-based case-control study.

Modelling issues in cancer screening.

Nation-wide breast cancer screening in The Netherlands: results of initial and subsequent screening 1990-1995. National Evaluation Team for Breast Cancer Screening.

Nation-wide breast cancer screening in the Netherlands: Support for breast-cancer mortality reduction

National Polyp Study data: evidence for regression of adenomas

Nationwide breast cancer screening programme fully implemented in The Netherlands

Neighborhood design and walking trips in ten U.S. metropolitan areas.

No increased risk for cervical cancer after a broader definition of a negative Pap smear

Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends

Pathologic Features of Prostate Cancer Found at Population-Based Screening With a Four-Year Interval

Prostate cancer mortality reduction by screening: Power and time frame with complete enrollment in the European randomised screening for prostate cancer (ERSPC) trial

Prostate-specific antigen screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer-Rotterdam.

Quantitative Interpretation of Age-Specific Mortality Reductions From the Swedish Breast Cancer-Screening Trials

Quebec randomized controlled trial on prostate cancer screening shows no evidence for mortality reduction

Radiation risk of mammography related to benefit in screening programmes: a favourable balance?

Re: Improving the Cost-Effectiveness of Colorectal Cancer Screening

Reducing the global burden of acute lower respiratory infections in children: the contribution of new diagnostics

Screening for breast cancer. Incidence of interval cancer and detection rate of first screenings are inconsistent.

Seventy-five years is an appropriate upper age limit for population-based mammography screening

Simulation of colorectal cancer screening: What we do and do not know and does it matter ⬇️

Stage distribution at first and repeat examinations in breast cancer screening

The MISCAN-COLON Simulation Model for the Evaluation of Colorectal Cancer Screening

Transmission patterns of smallpox: systematic review of natural outbreaks in Europe and North America since World War II.

Validity of Race, Ethnicity, and National Origin in Population-based Cancer Registries and Rapid Case Ascertainment Enhanced With a Spanish Surname List ⬇️

Withdrawing low risk women from cervical screening programmes. Conclusions cannot yet be drawn